BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28179305)

  • 1. The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer.
    Murata Y; Kokuryo T; Yokoyama Y; Yamaguchi J; Miwa T; Shibuya M; Yamamoto Y; Nagino M
    Anticancer Res; 2017 Feb; 37(2):589-598. PubMed ID: 28179305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects of α-bisabolol against pancreatic cancer.
    Seki T; Kokuryo T; Yokoyama Y; Suzuki H; Itatsu K; Nakagawa A; Mizutani T; Miyake T; Uno M; Yamauchi K; Nagino M
    Cancer Sci; 2011 Dec; 102(12):2199-205. PubMed ID: 21883695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Bisabolol Inhibits Invasiveness and Motility in Pancreatic Cancer Through KISS1R Activation.
    Uno M; Kokuryo T; Yokoyama Y; Senga T; Nagino M
    Anticancer Res; 2016 Feb; 36(2):583-9. PubMed ID: 26851012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
    Zhao M; Tang SN; Marsh JL; Shankar S; Srivastava RK
    Cancer Lett; 2013 Sep; 337(2):210-7. PubMed ID: 23684930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-18, a stemonamide synthetic intermediate inhibits Pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug.
    Wang Z; Li XM; Shang K; Zhang P; Wang CF; Xin YH; Zhou L; Li YY
    Oncol Rep; 2013 Mar; 29(3):1245-51. PubMed ID: 23314349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W; Adachi M; Zhang R; Zhou J; Zhu D
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model.
    Takiguchi S; Nishino Y; Inoue K; Ikeda M; Kataoka Y; Matsusue K; Nishiyama K; Iguchi H
    Oncol Rep; 2012 Jul; 28(1):111-6. PubMed ID: 22484715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
    Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
    BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel derivative of valepotriate inhibits the PI3K/AKT pathway and causes Noxa-dependent apoptosis in human pancreatic cancer cells.
    Yan YY; Shi KY; Teng F; Chen J; Che JX; Dong XW; Lin NM; Zhang B
    Acta Pharmacol Sin; 2020 Jun; 41(6):835-842. PubMed ID: 32047260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methylhemeanthidine chloride, a novel Amaryllidaceae alkaloid, inhibits pancreatic cancer cell proliferation via down-regulating AKT activation.
    Guo G; Yao G; Zhan G; Hu Y; Yue M; Cheng L; Liu Y; Ye Q; Qing G; Zhang Y; Liu H
    Toxicol Appl Pharmacol; 2014 Nov; 280(3):475-83. PubMed ID: 25151971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new protoapigenone analog RY10-4 induces apoptosis and suppresses invasion through the PI3K/Akt pathway in human breast cancer.
    Yuan Q; Cai S; Zhang X; Liu Z; Li Z; Luo X; Xiong C; Wang J; Hu J; Ruan J
    Cancer Lett; 2012 Nov; 324(2):210-20. PubMed ID: 22652174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer.
    Kano MT; Kokuryo T; Baba T; Yamazaki K; Yamaguchi J; Sunagawa M; Ogura A; Watanabe N; Onoe S; Miyata K; Mizuno T; Uehara K; Igami T; Yokoyama Y; Ebata T; Nagino M
    Anticancer Res; 2023 Mar; 43(3):1009-1016. PubMed ID: 36854520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide prohibits proliferation and enhances chemosensitivity of pancreatic cancer cells through deregulating SIRT1 and Ras/Akt pathways.
    Zhang JG; Zhao G; Qin Q; Wang B; Liu L; Liu Y; Deng SC; Tian K; Wang CY
    Pancreatology; 2013; 13(2):140-6. PubMed ID: 23561972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-Bisabolol, a nontoxic natural compound, strongly induces apoptosis in glioma cells.
    Cavalieri E; Mariotto S; Fabrizi C; de Prati AC; Gottardo R; Leone S; Berra LV; Lauro GM; Ciampa AR; Suzuki H
    Biochem Biophys Res Commun; 2004 Mar; 315(3):589-94. PubMed ID: 14975741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a phenanthrene derivative as a potent anticancer drug with Pim kinase inhibitory activity.
    Wang YY; Taniguchi T; Baba T; Li YY; Ishibashi H; Mukaida N
    Cancer Sci; 2012 Jan; 103(1):107-15. PubMed ID: 21981263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway.
    Liu W; Furuta E; Shindo K; Watabe M; Xing F; Pandey PR; Okuda H; Pai SK; Murphy LL; Cao D; Mo YY; Kobayashi A; Iiizumi M; Fukuda K; Xia B; Watabe K
    Breast Cancer Res Treat; 2011 Jul; 128(1):57-68. PubMed ID: 20665104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into the apoptosis-inducing action of alpha-bisabolol towards malignant tumor cells: involvement of lipid rafts and Bid.
    Darra E; Abdel-Azeim S; Manara A; Shoji K; Maréchal JD; Mariotto S; Cavalieri E; Perbellini L; Pizza C; Perahia D; Crimi M; Suzuki H
    Arch Biochem Biophys; 2008 Aug; 476(2):113-23. PubMed ID: 18291090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis-inducing ability.
    Li YY; Wang YY; Taniguchi T; Kawakami T; Baba T; Ishibashi H; Mukaida N
    Int J Cancer; 2010 Jul; 127(2):474-84. PubMed ID: 19921695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway.
    Chen J; Wang T; Xu S; Zhang P; Lin A; Wu L; Yao H; Xie W; Zhu Z; Xu J
    Eur J Med Chem; 2017 Jul; 135():414-423. PubMed ID: 28463784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancer.
    Takiguchi S; Inoue K; Matsusue K; Furukawa M; Teramoto N; Iguchi H
    Int J Oncol; 2017 Jul; 51(1):184-192. PubMed ID: 28498406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.